Daily Study

A broad down session: SPY −1.98%, QQQ −2.19%

Three screens filtered 1,906 US stocks down to 12 names on this page: the top and the bottom of each ordering. 10 of 12 closed lower and 1 higher; small caps (IWM) moved −2.20%.

SPY−1.98%
S&P 500 ETF715.84
QQQ−2.19%
Nasdaq 100 ETF645.10
IWM−2.20%
Russell 2000 ETF264.21
DIA−2.18%
Dow 30 ETF490.75
names screened
1,906
studied in depth
145
on this page
12
screens
3

A record of what moved, not a recommendation.Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRLMethodologyDisclaimer

Each screen starts from a broad filter of US stocks; the candidates are then ordered by a combined fundamentals-and-trend read. The page shows the names at the top and at the bottom of that order, so you see both ends of the same filter, not a pick list. Open any case study for the session, the three-month trend and the latest SEC financials. IEX volume is only the share traded on IEX, so it is compared with its own 20-day average.

Learn more: Top and Bottom of the Screen: An Ordering, Not a Verdict · Computer Hardware: Reading a Sector Where Units Fall and Revenue Rises · Building a Technical Analysis Checklist · Return on Equity and Leverage

527matched the screen
60studied in depth
4on this page

Top of the screen

TCPC

BlackRock TCP Capital Corp

4.08−0.4%
FinancialAsset Management
3 months−0.1%
52-week range52w low31%high
RSI (14)47
Session
at VWAP 4.060.71× avg vol
Moving averages
below 50dabove 200d
View TCPC chart on TradingView Affiliate
Case study: why TCPC is on this page

Top of this screen: a net loss last fiscal year; above its 200-day average.

Close 4.08: −0.4% vs previous closeSession (open→close): 0.0%

Session: day range 4.03–4.08, VWAP 4.06 (at VWAP), IEX volume 0.71× its 20-day average. Trend: −0.1% over three months, 31% of the way up its 52-week range, RSI(14) 47, below its 50-day and above its 200-day average.

Intraday chart of TCPC on 2026-11-19
Session (intraday)
Three-month daily chart of TCPC
Three months (daily)
Revenue (latest FY)
n/a
Net income (latest FY)
−$88.9M
Cash
$253.1M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: BlackRock TCP Capital Corp filings on SEC EDGAR

MYGN

Myriad Genetics Inc

5.55+0.2%
HealthcareDiagnostics & Research
3 months+82.6%
52-week range52w low53%high
RSI (14)52
Session
below VWAP 5.590.61× avg vol
Moving averages
above 50dabove 200d
View MYGN chart on TradingView Affiliate
Case study: why MYGN is on this page

Top of this screen: a net loss last fiscal year; revenue -1.6% YoY; above its 200-day average; +82.6% over 3 months.

Close 5.55: +0.2% vs previous closeSession (open→close): −2.8%

Session: day range 5.46–5.71, VWAP 5.59 (below VWAP), IEX volume 0.61× its 20-day average. Trend: +82.6% over three months, 53% of the way up its 52-week range, RSI(14) 52, above its 50-day and above its 200-day average.

Intraday chart of MYGN on 2026-11-19
Session (intraday)
Three-month daily chart of MYGN
Three months (daily)
Revenue (latest FY)
$824.5M
Net income (latest FY)
−$365.9M
Cash
$107.1M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Myriad Genetics Inc filings on SEC EDGAR

Bottom of the screen

NB

NioCorp Developments Ltd

2.46−3.0%
Basic MaterialsOther Industrial Metals & Mining
3 months−42.2%
52-week range52w low1%high
RSI (14)34
Session
at VWAP 2.460.79× avg vol
Moving averages
below 50dbelow 200d
View NB chart on TradingView Affiliate
Case study: why NB is on this page

Bottom of this screen: a net loss last fiscal year; below its 200-day average; near its 52-week low; -42.2% over 3 months.

Close 2.46: −3.0% vs previous closeSession (open→close): −5.2%

Session: day range 2.40–2.59, VWAP 2.46 (at VWAP), IEX volume 0.79× its 20-day average. Trend: −42.2% over three months, 1% of the way up its 52-week range, RSI(14) 34, below its 50-day and below its 200-day average.

Intraday chart of NB on 2026-11-19
Session (intraday)
Three-month daily chart of NB
Three months (daily)
Revenue (latest FY)
n/a
Net income (latest FY)
−$48.6M
Cash
$403.4M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: NioCorp Developments Ltd filings on SEC EDGAR

CABA

Cabaletta Bio Inc

1.01−3.8%
HealthcareBiotechnology
3 months−67.2%
52-week range52w low1%high
RSI (14)29
Session
below VWAP 1.030.57× avg vol
Moving averages
below 50dbelow 200d
View CABA chart on TradingView Affiliate
Case study: why CABA is on this page

Bottom of this screen: a net loss last fiscal year; below its 200-day average; near its 52-week low; -67.2% over 3 months.

Close 1.01: −3.8% vs previous closeSession (open→close): −2.4%

Session: day range 0.99–1.07, VWAP 1.03 (below VWAP), IEX volume 0.57× its 20-day average. Trend: −67.2% over three months, 1% of the way up its 52-week range, RSI(14) 29, below its 50-day and below its 200-day average.

Intraday chart of CABA on 2026-11-19
Session (intraday)
Three-month daily chart of CABA
Three months (daily)
Revenue (latest FY)
n/a
Net income (latest FY)
−$167.9M
Cash
$299.4M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Cabaletta Bio Inc filings on SEC EDGAR

1,354matched the screen
60studied in depth
4on this page

Top of the screen

UPBD

Upbound Group Inc

24.89−5.6%
TechnologySoftware - Application
3 months+29.9%
52-week range52w low87%high
RSI (14)65
Session
below VWAP 25.420.95× avg vol
Moving averages
above 50dabove 200d
View UPBD chart on TradingView Affiliate
Case study: why UPBD is on this page

Top of this screen: profitable last fiscal year; revenue +8.7% YoY; above its 200-day average; +29.9% over 3 months.

Close 24.89: −5.6% vs previous closeSession (open→close): −1.4%

Session: day range 24.84–26.11, VWAP 25.42 (below VWAP), IEX volume 0.95× its 20-day average. Trend: +29.9% over three months, 87% of the way up its 52-week range, RSI(14) 65, above its 50-day and above its 200-day average.

Intraday chart of UPBD on 2026-11-19
Session (intraday)
Three-month daily chart of UPBD
Three months (daily)
Revenue (latest FY)
$4.70B
Net income (latest FY)
$73.2M
Cash
$125.1M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Upbound Group Inc filings on SEC EDGAR

KIM

Kimco Realty Corp

25.33−1.2%
Real EstateREIT - Retail
3 months+4.5%
52-week range52w low81%high
RSI (14)61
Session
at VWAP 25.301.10× avg vol
Moving averages
above 50dabove 200d
View KIM chart on TradingView Affiliate
Case study: why KIM is on this page

Top of this screen: profitable last fiscal year; revenue +5.1% YoY; above its 200-day average.

Close 25.33: −1.2% vs previous closeSession (open→close): −0.4%

Session: day range 25.15–25.48, VWAP 25.30 (at VWAP), IEX volume 1.10× its 20-day average. Trend: +4.5% over three months, 81% of the way up its 52-week range, RSI(14) 61, above its 50-day and above its 200-day average.

Intraday chart of KIM on 2026-11-19
Session (intraday)
Three-month daily chart of KIM
Three months (daily)
Revenue (latest FY)
$2.14B
Net income (latest FY)
$584.7M
Cash
$699.2M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Kimco Realty Corp filings on SEC EDGAR

Bottom of the screen

ANNX

Annexon Inc

3.40−3.5%
HealthcareBiotechnology
3 months−32.7%
52-week range52w low1%high
RSI (14)35
Session
below VWAP 3.470.55× avg vol
Moving averages
below 50dbelow 200d
View ANNX chart on TradingView Affiliate
Case study: why ANNX is on this page

Bottom of this screen: a net loss last fiscal year; below its 200-day average; near its 52-week low; -32.7% over 3 months.

Close 3.40: −3.5% vs previous closeSession (open→close): −5.8%

Session: day range 3.40–3.66, VWAP 3.47 (below VWAP), IEX volume 0.55× its 20-day average. Trend: −32.7% over three months, 1% of the way up its 52-week range, RSI(14) 35, below its 50-day and below its 200-day average.

Intraday chart of ANNX on 2026-11-19
Session (intraday)
Three-month daily chart of ANNX
Three months (daily)
Revenue (latest FY)
n/a
Net income (latest FY)
−$206.7M
Cash
$102.4M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Annexon Inc filings on SEC EDGAR

RCUS

Arcus Biosciences Inc

15.780.0%
HealthcareBiotechnology
3 months−47.7%
52-week range52w low1%high
RSI (14)29
Session
below VWAP 15.880.49× avg vol
Moving averages
below 50dbelow 200d
View RCUS chart on TradingView Affiliate
Case study: why RCUS is on this page

Bottom of this screen: a net loss last fiscal year; revenue -4.3% YoY; below its 200-day average; near its 52-week low; -47.7% over 3 months.

Close 15.78: 0.0% vs previous closeSession (open→close): −1.5%

Session: day range 15.68–16.36, VWAP 15.88 (below VWAP), IEX volume 0.49× its 20-day average. Trend: −47.7% over three months, 1% of the way up its 52-week range, RSI(14) 29, below its 50-day and below its 200-day average.

Intraday chart of RCUS on 2026-11-19
Session (intraday)
Three-month daily chart of RCUS
Three months (daily)
Revenue (latest FY)
$247.0M
Net income (latest FY)
−$353.0M
Cash
$151.0M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Arcus Biosciences Inc filings on SEC EDGAR

25matched the screen
25studied in depth
4on this page

Top of the screen

IDXX

Idexx Laboratories Inc

689.78−1.3%
HealthcareDiagnostics & Research
3 months+23.2%
52-week range52w low70%high
RSI (14)64
Session
at VWAP 690.130.54× avg vol
Moving averages
above 50dabove 200d
View IDXX chart on TradingView Affiliate
Case study: why IDXX is on this page

Top of this screen: profitable last fiscal year; revenue +10.4% YoY; above its 200-day average; +23.2% over 3 months.

Close 689.78: −1.3% vs previous closeSession (open→close): −0.6%

Session: day range 687.16–694.16, VWAP 690.13 (at VWAP), IEX volume 0.54× its 20-day average. Trend: +23.2% over three months, 70% of the way up its 52-week range, RSI(14) 64, above its 50-day and above its 200-day average.

Intraday chart of IDXX on 2026-11-19
Session (intraday)
Three-month daily chart of IDXX
Three months (daily)
Revenue (latest FY)
$4.30B
Net income (latest FY)
$1.06B
Cash
$197.5M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Idexx Laboratories Inc filings on SEC EDGAR

AAPL

Apple Inc

349.08−0.9%
TechnologyConsumer Electronics
3 months+12.5%
52-week range52w low90%high
RSI (14)53
Session
at VWAP 349.251.39× avg vol
Moving averages
above 50dabove 200d
View AAPL chart on TradingView Affiliate
Case study: why AAPL is on this page

Top of this screen: profitable last fiscal year; revenue +15.1% YoY; above its 200-day average; near its 52-week high.

Close 349.08: −0.9% vs previous closeSession (open→close): −1.1%

Session: day range 346.49–355.25, VWAP 349.25 (at VWAP), IEX volume 1.39× its 20-day average. Trend: +12.5% over three months, 90% of the way up its 52-week range, RSI(14) 53, above its 50-day and above its 200-day average.

Intraday chart of AAPL on 2026-11-19
Session (intraday)
Three-month daily chart of AAPL
Three months (daily)
Revenue (latest FY)
$478.83B
Net income (latest FY)
$132.18B
Cash
$36.30B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Apple Inc filings on SEC EDGAR

Bottom of the screen

NVDA

NVIDIA Corp

145.99−3.2%
TechnologySemiconductors
3 months−30.0%
52-week range52w low0%high
RSI (14)20
Session
below VWAP 151.450.87× avg vol
Moving averages
below 50dbelow 200d
View NVDA chart on TradingView Affiliate
Case study: why NVDA is on this page

Bottom of this screen: profitable last fiscal year; revenue +65.5% YoY; below its 200-day average; near its 52-week low; -30.0% over 3 months.

Close 145.99: −3.2% vs previous closeSession (open→close): −4.5%

Session: day range 145.71–158.11, VWAP 151.45 (below VWAP), IEX volume 0.87× its 20-day average. Trend: −30.0% over three months, 0% of the way up its 52-week range, RSI(14) 20, below its 50-day and below its 200-day average.

Intraday chart of NVDA on 2026-11-19
Session (intraday)
Three-month daily chart of NVDA
Three months (daily)
Revenue (latest FY)
$215.94B
Net income (latest FY)
$120.07B
Cash
$22.44B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: NVIDIA Corp filings on SEC EDGAR

ADBE

Adobe Inc

221.71−2.0%
TechnologySoftware - Application
3 months−19.7%
52-week range52w low18%high
RSI (14)33
Session
below VWAP 223.110.87× avg vol
Moving averages
below 50dbelow 200d
View ADBE chart on TradingView Affiliate
Case study: why ADBE is on this page

Bottom of this screen: profitable last fiscal year; revenue +10.5% YoY; below its 200-day average; -19.7% over 3 months.

Close 221.71: −2.0% vs previous closeSession (open→close): −1.9%

Session: day range 219.82–229.65, VWAP 223.11 (below VWAP), IEX volume 0.87× its 20-day average. Trend: −19.7% over three months, 18% of the way up its 52-week range, RSI(14) 33, below its 50-day and below its 200-day average.

Intraday chart of ADBE on 2026-11-19
Session (intraday)
Three-month daily chart of ADBE
Three months (daily)
Revenue (latest FY)
$23.77B
Net income (latest FY)
$7.13B
Cash
$4.36B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Adobe Inc filings on SEC EDGAR

The charts use the candlestick, VWAP and moving-average reading taught in our free courses. To pull up any of these tickers yourself, TradingView’s free plan covers it. Affiliate link: we may earn a commission if you subscribe, at no extra cost to you.

Reminder: nothing on this page is investment advice. These names appear because of where they landed in the screen, not because of any view on where the price goes next. Past performance does not indicate future results. See the Disclaimer.